These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6397653)

  • 1. [Histochemical investigation of carcinoembryonic antigen in lung cancer].
    Shirakusa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Nov; 22(11):1004-11. PubMed ID: 6397653
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen: immunohistologic identification in invasive and intraepithelial carcinomas of the lung.
    Pascal RR; Mesa-Tejada R; Bennett SJ; Garces A; Fenoglio CM
    Arch Pathol Lab Med; 1977 Nov; 101(11):568-71. PubMed ID: 334106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between serum carcinoembryonic antigen (CEA) level and microscopic features of lung cancer].
    Ochnio J; Szymańska D; Kwiek S; Rogińska E; Rowińska-Zakrzewska E
    Pneumonol Pol; 1984 Jul; 52(7):331-9. PubMed ID: 6093067
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoembryonic antigen fraction in lung cancer.
    Fong S; Leon V; Betancourt M; Guarnaluse R
    Neoplasma; 1983; 30(4):449-55. PubMed ID: 6310423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen in sputum cytology.
    Boon ME; Lindeman J; Meeuwissen AL; Otto AJ
    Acta Cytol; 1982; 26(4):389-94. PubMed ID: 6957087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
    Kozielski J; Seweryn J
    Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen in bronchogenic carcinoma.
    Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
    Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of CEA in sputum in examination of lung cancer].
    Muraoka H; Katoh H; Moriya H; Kimura K; Higuchi Y
    Rinsho Hoshasen; 1985 Mar; 30(3):379-84. PubMed ID: 2991629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation between immunologic control and prognosis in colo-rectal and pulmonary tumors].
    Stipa S; Schillaci A; Modini C
    Minerva Med; 1982 Apr; 73(18):1145-8. PubMed ID: 7078797
    [No Abstract]   [Full Text] [Related]  

  • 10. [A clinical evaluation using ELISA of monoclonal antibodies to CEA in the serum of patients with lung cancer].
    Cha RJ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Jun; 9(3):133-5, 188. PubMed ID: 3792145
    [No Abstract]   [Full Text] [Related]  

  • 11. [CEA distribution in BALF of lung cancer patients].
    Xu WB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):371-3. PubMed ID: 2855411
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
    Tatsuno I; Konishi K
    Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic value of serum and tissue CEA evaluation in lung cancer].
    Leonardo E; Navone R; Dogliotti C; Oliaro A
    Minerva Med; 1985 Nov; 76(44):2111-6. PubMed ID: 4069423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoembryonic antigen (CEA)].
    Antonić M; Djurić B
    Plucne Bolesti; 1984; 36(3-4):187-91. PubMed ID: 6533639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carcinoembryonic antigen (CEA) in the blood serum of patients with bronchogenic carcinoma and selected diseases of the respiratory tract].
    Szklarz E; Gawlikowski W
    Pneumonol Pol; 1989 Apr; 57(4):217-21. PubMed ID: 2628950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of isoantigens A, B, and H in carcinoma of the lung.
    Davidsohn I; Ni LY
    Am J Pathol; 1969 Nov; 57(2):307-34. PubMed ID: 4902573
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical localization of carcinoembryonic antigen (CEA), CEA-S, and nonspecific cross-reacting antigen (NCA) in carcinomas of lung.
    Sun NC; Edgington TD; Carpentier CL; McAfee W; Terry R; Bateman J
    Cancer; 1983 Nov; 52(9):1632-41. PubMed ID: 6311398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunopathological factors influencing the prognosis after resection of lung cancer].
    Zhang YF
    Zhonghua Wai Ke Za Zhi; 1990 Jul; 28(7):424-6, 446-7. PubMed ID: 2269051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor-associated antigens in bronchial cancer].
    Gropp C
    Fortschr Med; 1982 Jun; 100(23):1100-7. PubMed ID: 6286437
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical usefulness of the determination of the plasma level of carcinoembryonic antigen in the diagnosis of bronchial carcinoma].
    Romero Candeira S; Martín Serrano C; Senent Español C; López Martínez M; Padilla Navas I; Hernández Blasco L
    Med Clin (Barc); 1987 Apr; 88(14):529-33. PubMed ID: 3586744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.